Early Access — free while we kick the tires
EdgarHawk

Johnson David Michael

Director

Director
1 filing analyzed · 1 company · Latest 2025-05-20

Companies

Company Buys Sells Direction
Aura Biosciences, Inc. AURA 1 0 Net buying

Activity

May 2025
2025-05-20 Aura Biosciences, Inc. AURA
high
Buy
20,000 shares
$98,000
Significance 7/10

Director Johnson David Michael buys 20,000 shares (20.0K) of AURA at $4.90; stock -49.5% from 52-week high but +10.6% over 30 days.

Johnson David Michael purchased 20,000 shares at $4.90 on 2025-05-16, a price near the bottom of the 52-week range ($4.90–$11.74), increasing his holdings by 13.7%. His prior trades at AURA (5 of 5 prior buys) demonstrated strong timing, with all posts showing positive 90-day returns ranging from 8.4% to 20.4%. However, the company is deeply unprofitable with a net income of -$27.5M against a market cap of $298.1M, and the stock has declined 22.5% over the trailing 90 days despite the recent 30-day bounce of +10.6%. The purchase occurs at a severe discount to the 52-week high, but without additional context on company-specific catalysts or operational improvements, the financial deterioration and loss of 49.5% from peak valuations present meaningful headwinds to any recovery thesis.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access